These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1699766)

  • 21. The ability of systematic transrectal ultrasound guided biopsy to detect prostate cancer in men with the clinical diagnosis of benign prostatic hyperplasia.
    Coplen DE; Andriole GL; Yuan JJ; Catalona WJ
    J Urol; 1991 Jul; 146(1):75-7. PubMed ID: 1711588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of transurethral prostatectomy on serum prostate specific antigen.
    Vesey SG; Goble NM; Stower MJ; Hammonds JC; Smith PJ
    Br J Urol; 1988 Oct; 62(4):347-51. PubMed ID: 2461243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transrectal ultrasonography of the prostate--prolonged finger of the urologist].
    Aus G; Hugosson J
    Lakartidningen; 1992 Nov; 89(45):3827-31. PubMed ID: 1281251
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anatomoclinical and biologic correlations in prostatic pathology. Apropos of 150 case reports].
    Amiel J; Chevallier D; Peyrottes A; Benoliel J; Toubol J
    Ann Urol (Paris); 1989; 23(6):528-30. PubMed ID: 2482700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transperineal prostate needle biopsy guided by transurethral ultrasound in patients without a rectum.
    Seaman EK; Sawczuk IS; Fatal M; Olsson CA; Shabsigh R
    Urology; 1996 Mar; 47(3):353-5. PubMed ID: 8633401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
    Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
    S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of prostate-specific antigen and prostate-specific antigen density with outcome of prostate biopsy.
    Bare R; Hart L; McCullough DL
    Urology; 1994 Feb; 43(2):191-6. PubMed ID: 7509526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The quotient of prostate-specific antigen and prostate volume. Improved differentiation between benign prostatic hyperplasia and locally circumscribed prostate cancer].
    Semjonow A; Hamm M; Rathert P
    Urologe A; 1993 May; 32(3):250-3. PubMed ID: 7685557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum prostate-specific antigen and prostate pathology in men having simple prostatectomy.
    Brawer MK; Rennels MA; Nagle RB; Schifman R; Gaines JA
    Am J Clin Pathol; 1989 Dec; 92(6):760-4. PubMed ID: 2480060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic accuracy of percent free prostate-specific antigen in prostatic pathology and its usefulness in monitoring prostatic cancer patients.
    Minardi D; Galosi AB; Recchioni A; Giammarco L; Polito M; Muzzonigro G
    Urol Int; 2001; 67(4):272-82. PubMed ID: 11741128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between serum prostate-specific antigen and calculated epithelial volume.
    Fukatsu A; Ono Y; Ito M; Yoshino Y; Hattori R; Gotoh M; Ohshima S
    Urology; 2003 Feb; 61(2):370-4. PubMed ID: 12597950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate-specific antigen and prostate gland volume: correlation and clinical application.
    Babaian RJ; Fritsche HA; Evans RB
    J Clin Lab Anal; 1990; 4(2):135-7. PubMed ID: 1690280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Volume determinations by transrectal ultrasonography in patients with benign prostatic hyperplasia: correlation with removed prostate weight.
    Alkan I; Türkeri L; Biren T; Cevik I; Akdaş A
    Int Urol Nephrol; 1996; 28(4):517-23. PubMed ID: 9119637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The incidence of lesions associated with prostatic biopsy and its effect on the serum concentration of the prostate-specific antigen].
    Morote Robles J; López López M; Encabo Duro G; de Torres Ramírez I
    Actas Urol Esp; 1999 May; 23(5):400-5. PubMed ID: 10427813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of prostate-specific antigen and prostate volume in patients with biopsy proven benign prostatic hyperplasia.
    Hochberg DA; Armenakas NA; Fracchia JA
    Prostate; 2000 Dec; 45(4):315-9. PubMed ID: 11102956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
    van Vuuren SP; Heyns CF; Zarrabi AD
    BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
    Haukaas S; Skaarland E; Halvorsen OJ; Stensland E; Farstad M
    Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2990-3. PubMed ID: 1700496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels.
    Nadler RB; Humphrey PA; Smith DS; Catalona WJ; Ratliff TL
    J Urol; 1995 Aug; 154(2 Pt 1):407-13. PubMed ID: 7541857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinicopathologic patterns of prostatic diseases and prostate cancer in Saudi patients.
    Mosli HA; Abdel-Meguid TA; Al-Maghrabi JA; Kamal WK; Saadah HA; Farsi HM
    Saudi Med J; 2009 Nov; 30(11):1439-43. PubMed ID: 19882057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of PSA auto-antibodies in men with prostate abnormalities (prostate cancer/benign prostatic hyperplasia/prostatitis).
    Lokant MT; Naz RK
    Andrologia; 2015 Apr; 47(3):328-32. PubMed ID: 24620795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.